Roche, Merck Partner on Cancer Therapy Diagnostics

The deal covers various technologies, including arrays and immunohistochemical technologies, and Merck will expand its use of Roche's investigational AmpliChip p53 assay.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.